NZ604009A - A combination composition comprising ibuprofen and paracetamol - Google Patents
A combination composition comprising ibuprofen and paracetamolInfo
- Publication number
- NZ604009A NZ604009A NZ60400911A NZ60400911A NZ604009A NZ 604009 A NZ604009 A NZ 604009A NZ 60400911 A NZ60400911 A NZ 60400911A NZ 60400911 A NZ60400911 A NZ 60400911A NZ 604009 A NZ604009 A NZ 604009A
- Authority
- NZ
- New Zealand
- Prior art keywords
- paracetamol
- ibuprofen
- approximately
- combination composition
- combination
- Prior art date
Links
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 title abstract 4
- HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 title abstract 4
- 229960001680 ibuprofen Drugs 0.000 title abstract 4
- 229960005489 paracetamol Drugs 0.000 title abstract 4
- 239000003814 drug Substances 0.000 abstract 2
- 206010061218 Inflammation Diseases 0.000 abstract 1
- 230000004054 inflammatory process Effects 0.000 abstract 1
- 238000001990 intravenous administration Methods 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Organic Chemistry (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Dermatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NZ60400911A NZ604009A (en) | 2010-07-07 | 2011-06-21 | A combination composition comprising ibuprofen and paracetamol |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NZ58666110 | 2010-07-07 | ||
PCT/NZ2011/000117 WO2012005605A1 (en) | 2010-07-07 | 2011-06-21 | A combination composition comprising ibuprofen and paracetamol |
NZ60400911A NZ604009A (en) | 2010-07-07 | 2011-06-21 | A combination composition comprising ibuprofen and paracetamol |
Publications (1)
Publication Number | Publication Date |
---|---|
NZ604009A true NZ604009A (en) | 2015-03-27 |
Family
ID=45441395
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NZ60400911A NZ604009A (en) | 2010-07-07 | 2011-06-21 | A combination composition comprising ibuprofen and paracetamol |
Country Status (6)
Country | Link |
---|---|
AU (1) | AU2011274652B2 (en) |
MY (1) | MY164112A (en) |
NZ (1) | NZ604009A (en) |
SG (1) | SG186388A1 (en) |
WO (1) | WO2012005605A1 (en) |
ZA (1) | ZA201208210B (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107519159A (en) * | 2010-11-04 | 2017-12-29 | 阿福特药物有限公司 | Compound |
CN103565733A (en) * | 2012-07-31 | 2014-02-12 | 南京帝易医药科技有限公司 | Ibuprofen sodium chloride injection preparation with pH of 6.0-6.5, and preparation method thereof |
US11197830B2 (en) | 2019-02-27 | 2021-12-14 | Aft Pharmaceuticals Limited | Pharmaceutical composition containing acetaminophen and ibuprofen |
WO2023281089A2 (en) | 2021-07-08 | 2023-01-12 | Krka, D.D., Novo Mesto | Pharmaceutical composition comprising naproxen and paracetamol |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1781277B1 (en) * | 2004-07-07 | 2012-02-01 | AFT Pharmaceuticals Limited | A combination composition comprising ibuprofen and paracetamol |
US20090264530A1 (en) * | 2008-04-16 | 2009-10-22 | Nickell Robert P | Combined nsaid and acetaminophen formulation and method |
-
2011
- 2011-06-21 MY MYPI2012005317A patent/MY164112A/en unknown
- 2011-06-21 NZ NZ60400911A patent/NZ604009A/en unknown
- 2011-06-21 WO PCT/NZ2011/000117 patent/WO2012005605A1/en active Application Filing
- 2011-06-21 SG SG2012093183A patent/SG186388A1/en unknown
- 2011-06-21 AU AU2011274652A patent/AU2011274652B2/en active Active
-
2012
- 2012-12-06 ZA ZA2012/08210A patent/ZA201208210B/en unknown
Also Published As
Publication number | Publication date |
---|---|
SG186388A1 (en) | 2013-01-30 |
MY164112A (en) | 2017-11-30 |
ZA201208210B (en) | 2014-04-30 |
WO2012005605A1 (en) | 2012-01-12 |
AU2011274652A1 (en) | 2013-01-10 |
AU2011274652B2 (en) | 2013-08-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH12021550804A1 (en) | A combination composition | |
IL201479A (en) | Use of tapentadol for the manufacture of a medicament for the treatment of pain | |
EA201290833A1 (en) | APPLICATION OF AMISULPRIDE AS ANTI-TRAFFIC MEANS | |
MY173215A (en) | Acetylcysteine compositions and methods of use thereof | |
NZ707377A (en) | Combination therapy methods for treating proliferative diseases | |
MX2011007589A (en) | Treatment of a cancer using a combination of bendamustine and an anti-cd20 antibody. | |
EA201270221A1 (en) | TREATMENT OF CROWN DISEASE WITH LACQUINIMODE | |
PE20142319A1 (en) | MULTIPLE SCLEROSIS TREATMENT WITH A COMBINATION OF LAQUINIMOD AND GLATIRAMER ACETATE | |
NZ612717A (en) | Treatment of pain associated with dislocation of basal endometrium | |
WO2007012022A3 (en) | Unit dose form with ibuprofen-famotidine admixture | |
MX358491B (en) | A pharmaceutical composition for treating cancer, comprising interferon alpha conjugate. | |
NZ595046A (en) | Compositions and methods for extended therapy with aminopyridines | |
JP2013541583A5 (en) | ||
MX2016011333A (en) | Drug delivery systems and methods for treatment of bladder cancer with gemcitabine. | |
WO2014071168A3 (en) | Administering inhibitors of tgfbeta signaling to improve muscle function in cancer patients | |
NZ591496A (en) | A medicinal comprising ibuprofen and paracetamol and treatment for arthritis | |
WO2008008882A3 (en) | Glucocorticoid receptor modulator and methods of use | |
NZ604009A (en) | A combination composition comprising ibuprofen and paracetamol | |
MY174442A (en) | Treating critically ill patients with intravenous ibuprofen | |
NZ597675A (en) | Medicament for the long term nsaid use | |
MX2011012668A (en) | Methods of administration of thrombopoietin agonist compounds. | |
UA61955U (en) | method for treating patients with erythematous-bullous erysipelas | |
RU2012158011A (en) | METHOD AND COMPOSITION FOR TREATMENT OF CANCER | |
RU2010124455A (en) | METHOD FOR TREATING SUFFERED WITH COMBINED CRANIO-BRAIN INJURY | |
AR075414A1 (en) | COMPOSITIONS AND METHODS FOR EXTENDED THERAPY WITH AMINOPIRIDINS |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PSEA | Patent sealed | ||
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 3 YEARS UNTIL 21 JUN 2018 BY A J PIETRAS + CO Effective date: 20150630 |
|
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 21 JUN 2019 BY CPA GLOBAL Effective date: 20180517 |
|
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 21 JUN 2020 BY CPA GLOBAL Effective date: 20190516 |
|
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 21 JUN 2021 BY CPA GLOBAL Effective date: 20200521 |
|
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 21 JUN 2022 BY CPA GLOBAL Effective date: 20210520 |
|
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 21 JUN 2023 BY CPA GLOBAL Effective date: 20220519 |
|
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 21 JUN 2024 BY CPA GLOBAL Effective date: 20230518 |
|
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 21 JUN 2025 BY ABHISHEK KUMAR - CPA-PTO PAYMENTS Effective date: 20240517 |